Dr. Amen Ra Mashariki, director of AI and data strategies for the Bezos Earth Fund, has been named chair of the advisory board for The University of Baltimore’s new Center for AI Learning and Community-Engaged Innovation.
Members of The University of Baltimore community are in the local spotlight for their achievements in business, law and leadership. Both the Baltimore Business Journal and the Daily Record have included UBalt community members in their recent accolades.
An article in The Baltimore Sun explores the many reasons why more recent college graduates from Baltimore-area institutions—including The University of Baltimore—are choosing to live in the city.
The University of Baltimore is now accepting applications for the Fall 2025 cohort of Entrepreneurship Opportunity Scholars program. Students who meet the program's criteria are encouraged to apply before the July 31 deadline. If you're ready to turn your business idea into a thriving reality, wi...
University of Baltimore business student Tishawn Thomas, an Entrepreneurial Fellow and local fashion brand owner, will present Runway Revolution Season 3, an evening of bold and vibrant fashion, creativity, and storytelling, on Aug. 16.
The University of Baltimore is remembering the life and legacy of former School of Law Dean Laurence "Larry" Katz, who passed away on July 21, 2025.
Dr. Ivan Sascha Sheehan, associate dean and professor in The University of Baltimore's College of Public Affairs and a noted expert in international relations, says long-term conflict between Russia and Ukraine, together with a growing lack of stability in the Western Balkans, are prompting a par...
With AI literacy as a key deliverable, The University of Baltimore's second annual AI Summit left an array of impressions on attendees, including Claire Baytas, a senior analyst at Ithaka S+R.
Prof. Alan Lyles is principal author of a journal article from a symposium on global trends in the use of "biosimilars" - pharmaceuticals designed to have active properties similar to those of a drug that has previously been licensed.